Glatiramer in the treatment of multiple sclerosis.
Journal Information
Full Title: Int J Nanomedicine
Abbreviation: Int J Nanomedicine
Country: Unknown
Publisher: Unknown
Language: N/A
Publication Details
Subject Category: Nanotechnology
Available in Europe PMC: Yes
Available in PMC: Yes
PDF Available: No
Related Papers from Same Journal
Transparency Score
Transparency Indicators
Click on green indicators to view evidence textCore Indicators
"Disclosures SAR is currently doing clinical trials (funded by research grants)with Teva (makers of glatiramer acetate), Genentech, Biogen, and Berlex. He has been a consultant to and has received honoraria from Teva, Berlex, Genentech, Biogen, and Serono. EK and JM have no conflicts of interest to disclose."
"DisclosuresSAR is currently doing clinical trials (funded by research grants)with Teva (makers of glatiramer acetate), Genentech, Biogen, and Berlex. He has been a consultant to and has received honoraria from Teva, Berlex, Genentech, Biogen, and Serono. EK and JM have no conflicts of interest to disclose."
Additional Indicators
Assessment Info
Tool: rtransparent
OST Version: N/A
Last Updated: Aug 05, 2025